中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2009年
12期
1265-1267,1270
,共4页
黄红星%邹叔骋%李创华%曾其昌%罗宗晚%王琴%李凌%卢军%刘博%刘坤
黃紅星%鄒叔騁%李創華%曾其昌%囉宗晚%王琴%李凌%盧軍%劉博%劉坤
황홍성%추숙빙%리창화%증기창%라종만%왕금%리릉%로군%류박%류곤
微血管减压术%三叉神经痛%面肌痉挛%舌咽神经痛
微血管減壓術%三扠神經痛%麵肌痙攣%舌嚥神經痛
미혈관감압술%삼차신경통%면기경련%설인신경통
Microvascular decompression%Trigeminal neuralgia%Facial spasm%Glossopharyngeal neuralgia
目的 总结和分析微血管减压术(MVD)治疗脑神经血管压迫综合征的疗效与术后并发症. 方法 应用MVD治疗脑神经血管压迫综合征39例(三又神经痛19例,面肌痉挛18例,舌咽神经痛2例)并探讨手术技巧及术后并发症的防治.结果 2例舌咽神经痛患者和17例三叉神经痛患者术后疼痛立即消失,面肌痉挛患者中有16例术后痉挛立即消失.术后无血肿、感染、脑脊液漏、偏瘫和死亡病例.34例获随访,平均随访1.58年,其中32例效果良好. 结论 MVD治疗脑神经血管压迫综合征安全、微创、有效,是目前治疗脑神经血管压迫综合征的首选方法.
目的 總結和分析微血管減壓術(MVD)治療腦神經血管壓迫綜閤徵的療效與術後併髮癥. 方法 應用MVD治療腦神經血管壓迫綜閤徵39例(三又神經痛19例,麵肌痙攣18例,舌嚥神經痛2例)併探討手術技巧及術後併髮癥的防治.結果 2例舌嚥神經痛患者和17例三扠神經痛患者術後疼痛立即消失,麵肌痙攣患者中有16例術後痙攣立即消失.術後無血腫、感染、腦脊液漏、偏癱和死亡病例.34例穫隨訪,平均隨訪1.58年,其中32例效果良好. 結論 MVD治療腦神經血管壓迫綜閤徵安全、微創、有效,是目前治療腦神經血管壓迫綜閤徵的首選方法.
목적 총결화분석미혈관감압술(MVD)치료뇌신경혈관압박종합정적료효여술후병발증. 방법 응용MVD치료뇌신경혈관압박종합정39례(삼우신경통19례,면기경련18례,설인신경통2례)병탐토수술기교급술후병발증적방치.결과 2례설인신경통환자화17례삼차신경통환자술후동통립즉소실,면기경련환자중유16례술후경련립즉소실.술후무혈종、감염、뇌척액루、편탄화사망병례.34례획수방,평균수방1.58년,기중32례효과량호. 결론 MVD치료뇌신경혈관압박종합정안전、미창、유효,시목전치료뇌신경혈관압박종합정적수선방법.
Objective To summarize and analyze the efficacy of microvascular decompression (MVD) for cerebral neurovascular compression syndrome and its postoperative complications. Methods MVD was performed in 39 patients with cerebral neurovascular compression syndrome, including 19 with trigeminal neuralgia, 18 with facial spasm and 2 with glossopharyngeal neuralgia. The surgical techniques and prevention of postoperative complications were analyzed. Results The immediate relief of pain was succeed in 17 with trigeminal neuralgia and 2 with glossopharyngeal neuralgia and the spasm was eliminated in 16 with facial spasm right after the operation. No hematoma, infection, cerebrospinal fluid leakage or death appeared and the total effectiveness rate was 94.87%. Follow-up was performed in 34 with an average of 1.58 years and 32 were recorded with good results. Conclusion MVD for cerebral neurovascular compression syndrome is safe, minimally invasive and effective. It is by far the first choice in the treatment of cerebral neurovascular compression syndrome.
